oxprenolol has been researched along with Heart Failure in 8 studies
Oxprenolol: A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety.
Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Beta-blockers have solid documentation in preventing cardiovascular complications in the treatment of hypertension; atenolol, metoprolol, oxprenolol and propranolol demonstrate proven cardiovascular prevention in hypertension mega-trials." | 5.22 | Diverse pharmacological properties, trial results, comorbidity prescribing and neural pathophysiology suggest European hypertension guideline downgrading of beta-blockers is not justified. ( Esler, M; Grassi, G; Kjeldsen, SE; Kreutz, R; Mancia, G; Pathak, A, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (75.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Esler, M | 1 |
| Kjeldsen, SE | 1 |
| Pathak, A | 1 |
| Grassi, G | 1 |
| Kreutz, R | 1 |
| Mancia, G | 1 |
| Taylor, SH | 1 |
| Silke, B | 1 |
| Zilcher, H | 1 |
| Glogar, D | 1 |
| Muiesan, G | 1 |
| Valori, C | 1 |
| Lopatin, IuM | 1 |
| Ghani, P | 1 |
| Sinitsin, VE | 1 |
| Mareev, VIu | 1 |
| Singh, BN | 1 |
| Simpson, FO | 1 |
2 reviews available for oxprenolol and Heart Failure
| Article | Year |
|---|---|
Diverse pharmacological properties, trial results, comorbidity prescribing and neural pathophysiology suggest European hypertension guideline downgrading of beta-blockers is not justified.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Cardiovascular Diseases; Comorbidity | 2022 |
Beta-adrenergic receptor blocking drugs in hypertension.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Alprenolol; Antidepressive Agents; Antihy | 1974 |
1 trial available for oxprenolol and Heart Failure
| Article | Year |
|---|---|
[Potential possibilities of using adrenergic beta blockers in chronic heart failure].
Topics: Adolescent; Adult; Aged; Chronic Disease; Female; Heart Failure; Hemodynamics; Humans; Male; Metopro | 1992 |
5 other studies available for oxprenolol and Heart Failure
| Article | Year |
|---|---|
Haemodynamic effects of beta-blockade in ischaemic heart failure.
Topics: Chronic Disease; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Male; Middle Aged; Oxprenolo | 1981 |
Alternatives to practolol - the argument in more detail.
Topics: Adrenergic beta-Antagonists; Heart Failure; Humans; Oxprenolol; Practolol; Propranolol | 1975 |
[Non arrhythmogenic sudden death as complication of coronary heart disease].
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Coronary Artery Bypass; Coronary Disease; Death, | 1979 |
[Sympathetic nervous activity and ischemic cardiopathy].
Topics: Aged; Angina Pectoris; Catecholamines; Coronary Disease; Heart Failure; Humans; Male; Middle Aged; M | 1977 |
Clinical aspects of the anti-arrhythmic actions of beta-receptor blocking drugs. 2. Clinical pharmacology.
Topics: Adrenergic beta-Antagonists; Alprenolol; Arrhythmias, Cardiac; Drug Therapy, Combination; Heart Fail | 1973 |